A citation-based method for searching scientific literature

Morgan L Maeder, Michael Stefanidakis, Christopher J Wilson, Reshica Baral, Luis Alberto Barrera, George S Bounoutas, David Bumcrot, Hoson Chao, Dawn M Ciulla, Jennifer A DaSilva, Abhishek Dass, Vidya Dhanapal, Tim J Fennell, Ari E Friedland, Georgia Giannoukos, Sebastian W Gloskowski, Alexandra Glucksmann, Gregory M Gotta, Hariharan Jayaram, Scott J Haskett, Bei Hopkins, Joy E Horng, Shivangi Joshi, Eugenio Marco, Rina Mepani, Deepak Reyon, Terence Ta, Diana G Tabbaa, Steven J Samuelsson, Shen Shen, Maxwell N Skor, Pam Stetkiewicz, Tongyao Wang, Clifford Yudkoff, Vic E Myer, Charles F Albright, Haiyan Jiang. Nat Med 2019
Times Cited: 274



Wenhan Yu, Suddhasil Mookherjee, Vijender Chaitankar, Suja Hiriyanna, Jung-Woong Kim, Matthew Brooks, Yasaman Ataeijannati, Xun Sun, Lijin Dong, Tiansen Li, Anand Swaroop, Zhijian Wu. Nat Commun 2017
Times Cited: 166




List of shared articles



Times cited

Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities.
Nina Schneider, Yogapriya Sundaresan, Prakadeeswari Gopalakrishnan, Avigail Beryozkin, Mor Hanany, Erez Y Levanon, Eyal Banin, Shay Ben-Aroya, Dror Sharon. Prog Retin Eye Res 2022
2

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges.
Eman A Taha, Joseph Lee, Akitsu Hotta. J Control Release 2022
10

Basic Principles and Clinical Applications of CRISPR-Based Genome Editing.
Jung Min Lim, Hyongbum Henry Kim. Yonsei Med J 2022
2

New Editing Tools for Gene Therapy in Inherited Retinal Dystrophies.
Juliette Pulman, José-Alain Sahel, Deniz Dalkara. CRISPR J 2022
0

Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors.
Marta Zuzic, Johannes Striebel, Julia S Pawlick, Kritika Sharma, Frank G Holz, Volker Busskamp. Prog Retin Eye Res 2022
1


The application and progression of CRISPR/Cas9 technology in ophthalmological diseases.
Xumeng Hu, Beibei Zhang, Xiaoli Li, Miao Li, Yange Wang, Handong Dan, Jiamu Zhou, Yuanmeng Wei, Keke Ge, Pan Li,[...]. Eye (Lond) 2022
0

Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing.
Hao Tang, Xiaohui Zhao, Xingyu Jiang. Adv Drug Deliv Rev 2021
14


Genome-Editing Strategies for Treating Human Retinal Degenerations.
Joel Quinn, Ayesha Musa, Ariel Kantor, Michelle E McClements, Jasmina Cehajic-Kapetanovic, Robert E MacLaren, Kanmin Xue. Hum Gene Ther 2021
14


Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
Clarissa Patrizi, Manel Llado, Daniela Benati, Carolina Iodice, Elena Marrocco, Rosellina Guarascio, Enrico M Surace, Michael E Cheetham, Alberto Auricchio, Alessandra Recchia. Am J Hum Genet 2021
15

CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing.
Ishani Dasgupta, Terence R Flotte, Allison M Keeler. Hum Gene Ther 2021
11